Ultra-low-dose rivaroxaban in very elderly patients with atrial fibril

Introduction

Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia globally, with epidemiological studies projecting its prevalence to escalate in parallel with population aging trends.1 Notably, individuals aged ≥80…

Continue Reading